GSK plc
Research GSK plc (GS71) on Bullrun: market cap EUR 86.64B, P/E 15.8, dividend yield 2.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGS71
- ExchangeXETRA
- CountryUnited Kingdom
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencyEUR
- Market capEUR 86.64B
- P/E15.8
- Dividend yield2.8%
- Financial periodQ2 2026
- RevenueGBP 8.41B
- Net incomeGBP 435.00M
- Free cash flowGBP 2.04B
- Gross margin73.1%
Valuation Snapshot
latest market cap is EUR 86.64B; P/E is 15.8; dividend yield is 2.8%.
Peer valuation comparison
Latest P/E is 15.79x versus a Healthcare sector median of 24.46x (35.5% below).
Latest dividend yield is 2.75% versus a Healthcare sector median of 2.11% (30.3% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 32.67B | GBP 6.29B | GBP 6.39B | 72.4% | 1.39 | GBP 3.40B | GBP 17.72B | GBP 16.38B |
| FY2024 | GBP 31.38B | GBP 2.95B | GBP 5.16B | 71.2% | 0.62 | GBP 3.87B | GBP 16.99B | GBP 13.67B |
| FY2023 | GBP 30.33B | GBP 5.31B | GBP 5.45B | 71.8% | 1.2 | GBP 2.94B | GBP 18.02B | GBP 12.80B |
| FY2022 | GBP 29.32B | GBP 15.62B | GBP 6.26B | 67.4% | 3.66 | GBP 3.72B | GBP 20.99B | GBP 10.10B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-28 | EUR 86.64B | 15.8 | 3.7% | 0.8 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.8 EUR, yield 2.8%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.74 GBP |
| FY2024 | 0.71 GBP |
| FY2023 | 0.65 GBP |
| FY2022 | 0.88 GBP |
About GSK plc
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is GSK plc's market cap?
GSK plc's market capitalization is EUR 86.64B.
What is GSK plc's P/E ratio?
GSK plc's price-to-earnings (P/E) ratio is 15.8.
Does GSK plc pay a dividend?
GSK plc has a dividend yield of 2.8%.
What does GSK plc do?
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer.